Nikki Bloch

RGCC

We are experts in developing and providing personalized cancer genetics tests for doctors and patients, and testing tumours for sensitivity and resistance to chemotherapy treatment and a range of natural substances. Established in 2004 with headquarters in Switzerland, we are also actively involved in pharmaceutical research and development. Our facilities are equipped with the most technologically advanced equipment and specialized software for data analysis. We work in collaboration with branch offices and distributors to provide a worldwide service.